Alnylam Pharma (ALNY) out of the money July puts and January 260 calls active as share price up 38%

Alnylam Pharma (NASDAQ: ALNY) 30-day option implied volatility is at 42; compared to its 52-week range of 33 to 408 as share price up 38% to $229.30 after reports results from its HELIOS-B Phase 3 study of vutrisiran. July 105 puts and 110 puts, September 85 puts and January 260 calls active at $13.20.

You May Also Be Interested In

• iShares Silver Trust (SLV) call put ratio 1.3 calls to 1 put as silver pulls back
• Qualcomm (QCOM) PT Raised to $190 at Susquehanna
• Needham Reiterates Hold Rating on Nike (NKE)